Gefitinib as First Line Therapy for Advanced or Metastatic NSCLC Patients in Southern Taiwan: P-1–150


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles